| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 640.2 | 632.6 | 579.0 |
| Other income | 15.4 | 15.6 | 21.0 |
| Total income | 655.6 | 648.2 | 599.9 |
| Profit before exceptional items & tax | 51.6 | 49.0 | 47.4 |
| Exceptional items | -24.3 | 0.0 | -58.3 |
| Profit before tax | 27.4 | 49.0 | -10.8 |
| Net profit | 22.2 | 41.5 | -11.9 |
| Operating margin | 4.2% | 7.6% | -1.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | -46.50% |
|---|---|
| Revenue, year on year | +10.60% |
| Operating profit, year on year | +37.10% |
| Operating profit, quarter on quarter | +8.40% |
NSE results filing, NSE: UNICHEMLAB. Figures extracted from the filing.
Unichem Laboratories Ltd: key numbers
- Share price
- ₹518.75
- Market cap
- ₹3,652 Cr
- Revenue (annual)
- ₹2,202 Cr
- Net profit (annual)
- ₹252.8 Cr
- P/E (TTM)
- 12.0×Sector 41.3×
- Promoter holding
- 70.22%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Unichem Laboratories Ltd
All →Unichem Laboratories Board Meeting Date
Unichem Laboratories intimated that its Board will meet on November 4, 2026 to consider Q2 and H1 FY27 unaudited results. The meeting has not yet occurred.
Unichem Laboratories Other Announcement
Unichem Laboratories Limited submitted the quarterly compliance certificate under SEBI Regulation 74(5) as provided by its Registrar and Share Transfer Agent.
Unichem Laboratories Business Update
Unichem Laboratories received five procedural observations from the USFDA following an inspection of its Goa formulation facility. The company plans to respond within 15 days.
Unichem Laboratories Legal & Regulatory
Unichem Laboratories received a tax order from the Commissioner (Appeals, Thane) for a penalty and interest liability totaling ₹93.66 Crore. The company intends to file an appeal.
- Value
- ₹93.66 Cr
Unichem Laboratories Employee Stock Options
Unichem extended the exercise period for 3.75 lakh vested ESOP options from 30-Sep-2026 to 31-Mar-2027. The NRC approved the extension via circular resolution under the 2018 Scheme.
Unichem Laboratories Price Movement Clarification
Unichem Laboratories clarified that the recent spurt in trading volume is purely market-driven. The company confirmed it has no undisclosed price-sensitive information to report.